Drug-resistant malaria

John E. Hyde

doi:10.1016/j.pt.2005.08.020

Drug-resistant malaria

John E. Hyde

Research output: Contribution to journal › Article › peer-review

Abstract

In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here. © 2005 Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	494-498
Number of pages	4
Journal	Trends in parasitology
Volume	21
Issue number	11
DOIs	https://doi.org/10.1016/j.pt.2005.08.020
Publication status	Published - Nov 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pt.2005.08.020

Cite this

@article{684670c551bb41549cd4c1afc4b2713a,

title = "Drug-resistant malaria",

abstract = "In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here. {\textcopyright} 2005 Elsevier Ltd. All rights reserved.",

author = "Hyde, \{John E.\}",

year = "2005",

month = nov,

doi = "10.1016/j.pt.2005.08.020",

language = "English",

volume = "21",

pages = "494--498",

journal = "Trends in parasitology",

issn = "1471-4922",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - Drug-resistant malaria

AU - Hyde, John E.

PY - 2005/11

Y1 - 2005/11

N2 - In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here. © 2005 Elsevier Ltd. All rights reserved.

AB - In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here. © 2005 Elsevier Ltd. All rights reserved.

U2 - 10.1016/j.pt.2005.08.020

DO - 10.1016/j.pt.2005.08.020

M3 - Article

SN - 1471-4922

VL - 21

SP - 494

EP - 498

JO - Trends in parasitology

JF - Trends in parasitology

IS - 11

ER -

Drug-resistant malaria

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this